Boltwood Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $461K | Buy |
11,993
+5
| +0% | +$192 | 0.13% | 130 |
|
|
2025
Q1 | $464K | Sell |
11,988
-465
| -4% | -$18K | 0.14% | 124 |
|
|
2024
Q4 | $421K | Buy |
12,453
+1,120
| +10% | +$37.9K | 0.13% | 125 |
|
|
2024
Q3 | $463K | Buy |
11,333
+200
| +2% | +$8.18K | 0.14% | 124 |
|
|
2024
Q2 | $429K | Buy |
11,133
+270
| +2% | +$10.4K | 0.13% | 125 |
|
|
2024
Q1 | $466K | Buy |
10,863
+210
| +2% | +$9K | 0.14% | 119 |
|
|
2023
Q4 | $395K | Buy |
10,653
+865
| +9% | +$32.1K | 0.13% | 123 |
|
|
2023
Q3 | $355K | Buy |
9,788
+175
| +2% | +$6.34K | 0.13% | 120 |
|
|
2023
Q2 | $343K | Buy |
9,613
+190
| +2% | +$6.77K | 0.12% | 127 |
|
|
2023
Q1 | $335K | Buy |
9,423
+2,480
| +36% | +$88.2K | 0.13% | 126 |
|
|
2022
Q4 | $244K | Buy |
+6,943
| New | +$244K | 0.1% | 135 |
|
|
2022
Q2 | – | Sell |
-6,805
| Closed | -$371K | – | 153 |
|
|
2022
Q1 | $371K | Buy |
6,805
+11
| +0.2% | +$600 | 0.14% | 126 |
|
|
2021
Q4 | $374K | Sell |
6,794
-64
| -0.9% | -$3.52K | 0.14% | 124 |
|
|
2021
Q3 | $328K | Buy |
6,858
+594
| +9% | +$28.4K | 0.13% | 129 |
|
|
2021
Q2 | $312K | Buy |
6,264
+465
| +8% | +$23.2K | 0.13% | 132 |
|
|
2021
Q1 | $259K | Buy |
5,799
+965
| +20% | +$43.1K | 0.12% | 136 |
|
|
2020
Q4 | $222K | Sell |
4,834
-11,351
| -70% | -$521K | 0.11% | 137 |
|
|
2020
Q3 | $761K | Buy |
16,185
+200
| +1% | +$9.4K | 0.42% | 78 |
|
|
2020
Q2 | $815K | Buy |
15,985
+293
| +2% | +$14.9K | 0.49% | 70 |
|
|
2020
Q1 | $743K | Buy |
+15,692
| New | +$743K | 0.53% | 67 |
|